These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36287307)

  • 1. A population health assessment of screening mammography on breast cancer mortality in North Carolina.
    Burch AE; Irish WD; Wong JH
    Breast Cancer Res Treat; 2022 Dec; 196(3):647-656. PubMed ID: 36287307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The North Carolina Breast Cancer Screening Program: foundations and design of a model for reaching older, minority, rural women.
    Earp JA; Altpeter M; Mayne L; Viadro CI; O'Malley MS
    Breast Cancer Res Treat; 1995 Jul; 35(1):7-22. PubMed ID: 7612907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Breast Cancer Risks to Improve Care for an Increased-Risk Population within Eastern North Carolina.
    Shelton CH; Bowen C; Guenther WC; Jordan B; Boehmer LM; Weldon CB; Trosman JR; Ruiz A
    N C Med J; 2022; 83(3):221-228. PubMed ID: 35504701
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation between intervention exposures, changes in attitudes, and mammography use in the North Carolina Breast Cancer Screening Program.
    Rauscher GH; Earp JA; O'Malley M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):741-7. PubMed ID: 15159304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial and repeat mammography screening: different behaviors/different predictors.
    Mayne L; Earp J
    J Rural Health; 2003; 19(1):63-71. PubMed ID: 12585776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
    Bailey SL; Sigal BM; Plevritis SK
    J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing mammography utilization: a controlled study.
    Fletcher SW; Harris RP; Gonzalez JJ; Degnan D; Lannin DR; Strecher VJ; Pilgrim C; Quade D; Earp JA; Clark RL
    J Natl Cancer Inst; 1993 Jan; 85(2):112-20. PubMed ID: 8418300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of using mammography screening appointments to identify high-risk women: cross sectional survey results from the national health interview survey.
    Narayan AK; Mercaldo SF; Gupta YP; Warner ET; Lehman CD; Miles RC
    Breast Cancer Res Treat; 2021 Feb; 186(1):229-235. PubMed ID: 33180237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year risk of interval-invasive second breast cancer.
    Lee JM; Buist DS; Houssami N; Dowling EC; Halpern EF; Gazelle GS; Lehman CD; Henderson LM; Hubbard RA
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25904721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis.
    Su SY
    Breast Cancer; 2022 Mar; 29(2):336-342. PubMed ID: 34837139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study.
    Duffy SW; Tabár L; Yen AM; Dean PB; Smith RA; Jonsson H; Törnberg S; Chiu SY; Chen SL; Jen GH; Ku MM; Hsu CY; Ahlgren J; Maroni R; Holmberg L; Chen TH
    Radiology; 2021 Jun; 299(3):541-547. PubMed ID: 33650900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Literacy, Mammogram Awareness and Screening Among Tertiary Hospital Women Patients.
    Yılmazel G
    J Cancer Educ; 2018 Feb; 33(1):89-94. PubMed ID: 27236309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geospatial Associations between Female Breast Cancer Mortality Rates and Environmental Socioeconomic Indicators for North Carolina.
    Burwell A; Kimbro S; Mulrooney T
    Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race and mammography use in two North Carolina counties.
    O'Malley MS; Earp JA; Harris RP
    Am J Public Health; 1997 May; 87(5):782-6. PubMed ID: 9184506
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.